COMP <GO>
DLB vs BRK-A // ENTERPRISE SCALE & MARKET CAP
Dolby Laboratories (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: DLB 8
— BRK-A 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BRK-A
LAST: $61.99 (-1.46%) • MKT CAP: $5.89B
market-cap
$5.89B
LAST: $815,600.00 (-0.23%) • MKT CAP: $1.20T
market-cap
$1.20T
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DLB VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DLB | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.10% | 41.00% | +47.10 | DLB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.50% | 8.30% | +1.20 | DLB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.6x | 12.7x | +5.90 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 7.40% | 2.08% | +5.32 | DLB | /fcf-yield <GO> |
| Operating Margin | 19.60% | 33.00% | -13.40 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 18.90% | 27.10% | -8.20 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 5.90% | -1.00% | +6.90 | DLB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.15% | 0.00% | +2.15 | DLB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.20 | 3.02 | +5.18 | DLB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | DLB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.30% | -0.40 | DLB | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 67.2 | -11.55 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 1.13 | -0.13 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.5x | 16.7x | +4.80 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.89B | $1.20T | -$1.20T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DLB REV | BRK-A REV | DLB GROSS % | BRK-A GROSS % | DLB FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.35B | $247.24B | 88.1% | 44.0% | $435.9M | $25.04B |
| FY 2024 | $1.27B | $249.71B | 89.0% | 44.0% | $297.2M | $11.62B |
| FY 2023 | $1.30B | $254.91B | 44.0% | 44.0% | $308.6M | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DLB // BETA 1.00
BRK-A // BETA 1.13